TickerTalks
Browse all tickers →
TickerTalks›$VTR
VTVTR

Ventas, Inc.

$VTR·$45B·REIT - Healthcare Facilities·Real Estate
$91.18-0.7%1Y+34.2%
Mentions · last 7 days
2026-08-22: 2 posts2026-08-23: 3 posts2026-08-24: 1 posts22
Price updated 6h ago·X counts updated 7d ago
VTVTR
$VTRVentas, Inc.
$91.18-0.69%22 posts
AI analysisFundamentalsVoices on X
Loading…

What it does

Plain-English summary of the business — what they sell and how they make money.

Ventas is a healthcare REIT investing in senior housing communities, medical office buildings, and life science properties across the U.S. and Canada.

Industry overviewAI analysisGenerated by AI from underlying data

Where REIT - Healthcare Facilities sits in its cycle right now — and what that implies for $VTR.

REIT - Healthcare Facilities · Real Estate

Senior housing occupancy recovery post-COVID is the primary NOI driver; demographic tailwinds (aging Baby Boomers) provide a durable demand runway. Development costs and labor inflation are the margin headwinds.

What this means for $VTR

Partial — REIT cash flows tied to occupancy, rent growth, and cap rate environment; As an S&P 500 company, Ventas operates strategically at the nexus of the dynamic.

Industry benchmark

4-name peer basket
+20.3%YTD
+16.2%1Y

Fundamentals & catalyst

Profitability, valuation, and the next earnings event — at a glance, with rule-of-thumb signals.

Key ratios

P/E
169.9How much investors are paying per dollar of profit the company actually earned in the last 12 months. Lower means the stock looks cheaper relative to earnings.~15–25 is typical for the S&P 500; high-growth names trade 30+; hyper-growth or speculative can be 100+ or negative.
ROIC
22.3%What percentage return the business earns on every dollar of capital (equity + debt) deployed in operations. The cleanest measure of business quality.Above ~15% is high-quality; consistently above 25% suggests a real moat. Below the company's cost of capital is value-destroying.
Op margin
12.9%Operating profit (after sales, marketing, R&D, and overhead but before interest and taxes) as a percentage of revenue. The clearest view of how well the underlying business is run.Mature business above 20% is healthy; software businesses can run 30%+; commodity / retail businesses operate in single digits.
FCF yield
3.5%Free cash flow (operating cash flow minus capex) divided by the company's market cap. The cash-on-cash return you'd get owning the whole business at today's price.Above ~5% is attractive; below ~2% means you're paying up for growth. Capital-light businesses (software) run higher than capital-heavy ones (utilities).
P/S
7.1Same idea as P/E but per dollar of revenue. Useful for companies that aren't profitable yet, where P/E is meaningless.Under ~2 is cheap; software / SaaS often runs 8–15; well above 20 implies the market is pricing in very high future growth.
ROE
2.0%Net income as a percentage of shareholders' equity. Similar to ROIC but counts only the equity side.Above 20% is strong, but can be inflated by leverage — a heavily indebted company can show high ROE with weak underlying ROIC.
Gross margin
-2.6%Revenue minus the direct cost of producing what was sold, as a percentage of revenue. The first read on whether the product is structurally profitable.Software / SaaS is typically 70%+; consumer goods 30–50%; commodity / hardware businesses can be under 20%.
D/E
0.9Total debt divided by shareholders' equity. Measures how much the business runs on borrowed money versus owner capital.Under 1 is conservative; 1–2 is typical for mature businesses; over 2 is leveraged and more sensitive to interest rates.

Past earnings

QuarterReportedActualEstimateSurprise
Q2 2026Jul 29, 2026$0.14$0.14-1.6%
Q1 2026Apr 27, 2026$0.11$0.12-10.5%
Q4 2025Feb 5, 2026$0.15$0.10+49.0%
Q3 2025Oct 29, 2025$0.14$0.09+52.2%
Next earningsWed, Oct 28·consensus EPS $0.16

Quarterly trend

QuarterRevenueYoYGrossOpEPSFCF
Q2 FY26$1.7B+21.7%39.8%12.5%$0.14$1.5B
Q1 FY26$1.7B+22.0%39.6%11.6%$0.12$-576.9M
Q4 FY25$1.6B+21.7%-136%13.0%$0.15$367.7M
Q3 FY25$1.5B+20.4%41.6%14.9%$0.14$286.4M

Forward consensus

4-year forecast · up to 4 analysts
FYRevenueRangeEPSRangeAnalysts
FY26$6.9B$6.8B – $7.0B$0.60$0.59 – $0.604
FY27$7.6B$7.4B – $7.7B$0.97$0.93 – $1.014
FY28$8.4B$7.8B – $8.7B$1.28$0.87 – $1.444
FY29$9.1B$8.8B – $9.3B$1.94$1.86 – $1.992

Setup & momentum

Volume, range, and moving-average position — the technical setup driving short-term moves.

Right now

Vol vs 30dToday's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.1.3×Today's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.
52w rangeWhere the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.70%Where the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.
vs 50d MALatest close vs the 50-day simple moving average. Positive = short-term trend is up.-1.3%Latest close vs the 50-day simple moving average. Positive = short-term trend is up.
vs 200d MALatest close vs the 200-day simple moving average. Positive = long-term trend is up.+7.4%Latest close vs the 200-day simple moving average. Positive = long-term trend is up.

Float & profile

FloatHigh float · 510.1M shFree-float shares — the slice of issued stock actually available to trade. Lower buckets squeeze harder on a catalyst.Traded today0.8% of floatToday's volume as a percent of the free float. Above 5% on a single day is unusually high turnover for the available share count.β0.735-year weekly beta vs the S&P 500. Above 1.5 means the stock typically moves more than the index; below 0.8 moves less.

Insider activity

Recent open-market buys and sells by officers and directors — flagged when multiple insiders cluster.

Recent transactions

BuyJun 3Michael J EmblerDirector2.5K sh$197KSellMay 14Walter C RakowichDirector1.2K sh$104K
+ 37 other (36 awards · 1 inkind) in window

See when $VTR insiders are putting their own money in

  • Real-time open-market buys and sells from Form 4 filings
  • Cluster-buy detection when multiple insiders pile in at once
  • 30 / 60 / 180-day windows so you can spot building conviction
Free, forever. No credit card.

SEC filings

Material 8-K, 13D, S-3, and 424B5 events from the last 180 days — the filings that actually move the price.

Recent material filings

3New insider — initial holdingsAug 43
AI summary

A new Ventas director or officer filed Form 3 reporting no securities beneficially held — Tables I and II are both empty. Routine new-officer or director initial ownership disclosure with zero holdings at time of appointment.

8-KOfficer or director changeJun 158-K — Item 5.02: Officer or director change · Item 8.01: Other event
8-KOfficer or director changeMay 158-K — Item 5.02: Officer or director change · Item 5.07: Shareholder vote · Item 8.01: Other event
424B5Prospectus supplement (offering)May 15424B5
+ 15 other (6 13Gs · 2 13Fs · 2 10-Qs · 2 earnings 8-Ks) in window

Recent news

Latest headlines from major outlets, sourced and timestamped — context for whatever just moved.

Ventas (VTR) Up 1.1% Since Last Earnings Report: Can It Continue?zacks.com·4d agoAdelante Capital Management LLC Takes Position in Ventas, Inc. $VTRdefenseworld.net·5d agoCallan Family Office LLC Buys Shares of 25,940 Ventas, Inc. $VTRdefenseworld.net·9d agoAllworth Financial LP Takes $2.35 Million Position in Ventas, Inc. $VTRdefenseworld.net·10d agoVentas (VTR) Could Be a Great Choicezacks.com·15d ago

More in REIT - Healthcare Facilities

Peers in the same group — one click to compare setups, fundamentals, and chatter.

$LTC$WELL$DOC$AHR$SBRA$NHI
Voices on X · last 7 days

No standout posts about $VTR on X in the last 7 days.

TickerTalks is a research tool, not financial advice. We surface social-attention data; we do not make stock recommendations. Past attention is not predictive of future price movements.

PrivacyTermsSupport